Synklino
25+ years in life science and biotech. Previous Head of Virology and Life Science Engineering at DTU, DK, CEO at Inagen, Group leader at the National University Hospital and post doc. at Stanford University.
Synklino
1 followers
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.